Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bryant

Showing results (471-480 of 474) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 474 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancerKevin C Conlon, Enrico Lugli, Hugh C Welles, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
18-month outcomes of heterologous bilateral hand transplantation in a child: a case reportSandra Amaral, Sudha Kilaru Kessler, Todd J Levy, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphomaJohn E Janik, John C Morris, Deirdre O'Mahony, et al.
Contemporary Nurse|August 18, 2020
A unified call to action from Australian nursing and midwifery leaders: ensuring that Black lives matterL Geia, K Baird, K Bail, et al.
Pageof 48

Showing results (471-480 of 474) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 474 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancerKevin C Conlon, Enrico Lugli, Hugh C Welles, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
18-month outcomes of heterologous bilateral hand transplantation in a child: a case reportSandra Amaral, Sudha Kilaru Kessler, Todd J Levy, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphomaJohn E Janik, John C Morris, Deirdre O'Mahony, et al.
Contemporary Nurse|August 18, 2020
A unified call to action from Australian nursing and midwifery leaders: ensuring that Black lives matterL Geia, K Baird, K Bail, et al.
Pageof 48